Investment Analysts' New Coverage for May 31st (ACNB, ACOR,

Investment Analysts’ new coverage for Wednesday, May 31st: Hovde Group began coverage on shares of ACNB (NASDAQ:ACNB). The firm issued an outperform rating and a $36.00 target price on the stock. StockNews.com started coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). StockNews.com issued a buy rating on the stock. StockNews.com started coverage on shares of Advanced […]

Related Keywords

Colliers , Newfoundland , Canada , Duck Creek , Ontario , William Blair , Roth Mkm , Goldman Sachs Group Inc , Co Daily , Colliers International Group , Hovde Group , Hillman Solutions , Needham Company , Emissions Solutions , Royal Bank , Global Indemnity Group , Titan Pharmaceuticals , Terns Pharmaceuticals , China Yuchai International , Nasdaq , Healthcare Trust , Saga Communications , Investment Analyst , Acorda Therapeutics , Advanced Emissions Solutions , Duck Creek Technologies , Diversified Healthcare Trust , Goldman Sachs Group , Cedar Fair , Imperial Capital , Milestone Scientific , Near Intelligence , Northland Securities , Oncternal Therapeutics , Pretium Resources , Recordati Industria Chimica , Seaworld Entertainment , Noble Financial , Six Flags Entertainment , Sovos Brands , Strattec Security , World Wrestling Entertainment , Acnb Co , Acorda Therapeutics Inc , Advanced Emissions Solutions Inc , Argenx Se , Wbrc Inc , Bsquare Co , Colliers International Group Inc , Clearone Inc , Cps Technologies Co , China Yuchai International Limited ,